federal_register: 2024-27018
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-27018 | Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications | Rule | The Drug Enforcement Administration (DEA) in concert with the Department of Health and Human Services (HHS) is issuing a third extension of telemedicine flexibilities for the prescribing of controlled medications, through December 31, 2025. | 2024-11-19 | 2024 | 11 | https://www.federalregister.gov/documents/2024/11/19/2024-27018/third-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled | https://www.govinfo.gov/content/pkg/FR-2024-11-19/pdf/2024-27018.pdf | Justice Department; Drug Enforcement Administration; Health and Human Services Department | 268,116,221 | The Drug Enforcement Administration (DEA) in concert with the Department of Health and Human Services (HHS) is issuing a third extension of telemedicine flexibilities for the prescribing of controlled medications, through December 31, 2025. |